Baseline values of outcome parameters according to E-selectin genotype
. | S128 homozygosity, mean (95% CI) . | S128R polymorphism, mean (95% CI) . |
|---|---|---|
| Neutrophil counts, 109/L | 2.8 (2.6-3.1) | 2.7 (2.5-3.0) |
| Lymphocyte counts, 109/L | 2.6 (2.3-2.8) | 2.4 (2.1-2.7) |
| Monocyte counts, 109/L | 0.51 (0.47-0.56) | 0.48 (0.43-0.53) |
| Prothrombin fragment, nM | 0.60 (0.57-0.63) | 0.62 (0.53-0.71) |
| D-dimer, μg/L | 0.20 (0.16-0.24) | 0.24 (0.11-0.36) |
| Tissue factor mRNA, no. cycles | 34.9 (34.5-35.2) | 34.6 (34.0-35.2) |
| Tumor necrosis factor, pg/mL | 2.4 (1.8-3.0) | 2.9 (1.6-4.3) |
| Interleukin-6, pg/mL | 1.8 (1.3-2.4) | 1.5 (1.0-2.0) |
| Plasmin antiplasmin complexes, μg/L | 303 (266-341) | 324 (253-395) |
| Soluble E-selectin, ng/mL | 36.0 (33.6-38.4) | 32.8 (27.5-38.1) |
. | S128 homozygosity, mean (95% CI) . | S128R polymorphism, mean (95% CI) . |
|---|---|---|
| Neutrophil counts, 109/L | 2.8 (2.6-3.1) | 2.7 (2.5-3.0) |
| Lymphocyte counts, 109/L | 2.6 (2.3-2.8) | 2.4 (2.1-2.7) |
| Monocyte counts, 109/L | 0.51 (0.47-0.56) | 0.48 (0.43-0.53) |
| Prothrombin fragment, nM | 0.60 (0.57-0.63) | 0.62 (0.53-0.71) |
| D-dimer, μg/L | 0.20 (0.16-0.24) | 0.24 (0.11-0.36) |
| Tissue factor mRNA, no. cycles | 34.9 (34.5-35.2) | 34.6 (34.0-35.2) |
| Tumor necrosis factor, pg/mL | 2.4 (1.8-3.0) | 2.9 (1.6-4.3) |
| Interleukin-6, pg/mL | 1.8 (1.3-2.4) | 1.5 (1.0-2.0) |
| Plasmin antiplasmin complexes, μg/L | 303 (266-341) | 324 (253-395) |
| Soluble E-selectin, ng/mL | 36.0 (33.6-38.4) | 32.8 (27.5-38.1) |